← Back to headlines
Criticism Mounts Over BioNTech's Withdrawal from German Production
BioNTech's announced closure of its production facilities in Germany is drawing sharp criticism from figures like the CureVac founder and unions, with warnings of potential supply shortages.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
China’s Huawei, US PC maker HP sign multi-year Wi-Fi patent deal
9m ago
Nvidia Earnings Anticipated to Boost Asian Stocks and AI Market Confidence
28m ago
SpaceX Unveils Plans for $100 Billion Starship Launch Facility in Louisiana
57m ago
Amazon to Shut Down Crowdsourced Work Platform Mechanical Turk
1h ago